Osteoporosis Treatment Under COVID-19

A steering committee of the American Society for Bone Mineral Research recently issued COVID-19 treatment guidelines for patients receiving osteoporosis treatments. In this interview, E. Michael Lewiecki, M.D., director of the New Mexico Clinical Research and Osteoporosis Center and a University of New Mexico program called Bone Health TeleECHO, shares his best practices for treating osteoporosis patients during the pandemic.

Related Content:

Osteoporosis

E Michael Lewiecki, MD: Sequential Therapy in Osteoporosis

E Michael Lewiecki, MD: When is Osteopenia Osteoporosis?

Q&A: ACR’s Updated Guidelines for Prevention, Treatment of Glucocorticoid-Induced Osteoporosis